Who we are
Our mission is to enable globally scalable mass disease screening, for COVID-19 and beyond.
We are a Public Benefit Corporation focused on bringing to market a key capability that can help control the spread of this virus: affordable, distributed molecular testing. For many reasons, the molecular diagnostics industry and clinical lab business have not been able to meet this need at scale throughout the pandemic. At FloodLAMP, we have innovated on multiple fronts to create a best-of-class platform through:
- careful selection of the test chemistry (RT-LAMP),
- operationally efficient program design,
- a focus on user experience,
- integration with powerful digital tools.